Analysis of ADMET biological activity indicators of 1-(2-thienoyl)-3,3,3-trifluoroacetone acylhydrazones

View at publisher Summarise with VIRAT
Authors: Авезов Кувондик Гиясович, Nusratillo Rakhmatilloev, Gulruh Bakhshullayeva, Rumiya Sharafutdinova, Sitorabonu Zokirova
Cited by: 0
References: 16

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

The aim of this research was to conduct a comprehensive in silico evaluation of the ADMET biological activity properties of acylhydrazone derivatives (H2L1-H2L6) synthesized based on 1-(2-thienoyl)-3,3,3-trifluoroacetone. The synthesis was carried out at room temperature in ethanol, and the product yields were 60-70%. ADMET parameters were analyzed using the ADMETLAB online server. Analysis of physicochemical properties showed that the molecular weight ranged from 340.05 to 417.96 g/mol, and TPSA ranged from 58.53 to 101.67 Ų. QED values were in the range of 0.355-0.513, indicating that H2L1 has high drug-likeness. QED values ranged from 0.355 to 0.513, indicating that H2L1 has high drug-likeness properties. In terms of absorption parameters, H2L6 showed the highest PAMPA permeability (0.971), while H2L3 had the highest F50% bioavailability (0.768). Distribution analysis revealed that all compounds had high plasma protein binding (97.93–98.953%) and minimal BBB penetration (0.0–0.003). Metabolism characteristics showed that all compounds strongly inhibited CYP1A2, CYP2C19, and CYP2C8 enzymes. Excretion parameters indicated that H2L3 had the highest CLplasma (3.814) and the shortest T₁/₂ (0.942 hours), while H2L5 had the lowest CLplasma (1.573) and the longest T₁/₂ (1.373 hours). Analysis of all parameters demonstrated that H2L3 and H2L6 compounds are promising candidates for pharmaceutical development.

Fields of Study & Subjects

Computational Drug Discovery Methods Synthesis and Characterization of Heterocyclic Compounds Pharmacogenetics and Drug Metabolism

Publication details

Journal / source
International Conference on Optics, Materials Science, and Computing in Condensed-Matter Physics (OMCCP)
Pages
56–56
Publication date
30 March 2026
Language
EN